CME vs LPLA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 23, 2026

CME

60.8
AI Score
VS
CME Wins

LPLA

53.9
AI Score

Investment Advisor Scores

CME

Mar 23, 2026
61score
Recommendation
BUY

LPLA

Mar 23, 2026
54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME LPLA Winner
Forward P/E 26.1097 10.7066 LPLA
PEG Ratio 5.8703 0.384 LPLA
Revenue Growth 8.0% 41.8% LPLA
Earnings Growth 35.0% 4.6% CME
Tradestie Score 60.8/100 53.9/100 CME
Profit Margin 62.6% 5.2% CME
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY HOLD CME

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.